Sign In
Buy EIGR
$1.73
+0 (+0%)
At Close: Aug 27, 2024
Insider Buying: The Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Founder Just Bought US$151k Worth Of Shares
10:45am, Friday, 20'th Mar 2020
Potential Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) shareholders may wish to note that the Founder, Jeffrey Glenn...
Wedbush Sticks to Its Buy Rating for Eiger Biopharmaceuticals (EIGR)
03:46pm, Wednesday, 18'th Mar 2020
In a report released today, Liana Moussatos from Wedbush maintained a Buy rating on Eiger Biopharmaceuticals (EIGR – Research Report),
Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
12:00pm, Friday, 13'th Mar 2020
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today reported financial results for the
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
12:00am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 9.)
Arcutis...
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit hit 52-week highs March 5.) * Arcus Biosciences Inc (NYSE: RCUS) * Arcturu
Daily Insider Ratings Round Up 1/30/20
06:57pm, Monday, 03'rd Feb 2020
Tables of the top insider purchases and sales filed with the SEC on 1/30/20, based on dollar value. Dollar values often do not equate with significance when it
Analysts' Downgrades for January, 28th (ABBV, ACHC, ALGN, AMAT, ARGKF, ARWR, ATRC, ATVI, BGNE, BPFH)
08:26am, Tuesday, 28'th Jan 2020
Analysts’ downgrades for Tuesday, January 28th: AbbVie (NYSE:ABBV) was downgraded by analysts at ValuEngine from a hold rating to a sell rating. Acadia Healthcare (NASDAQ:ACHC) was downgraded by ana
Top Insider Buys Highlight for the Week of Jan. 17
08:04pm, Sunday, 19'th Jan 2020
Insiders invest in JPMorgan, Simply Good Foods, Eiger BioPharmaceuticals and Geron Continue reading...
Trade Alert: The Chairman Of Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR), Thomas Dietz, Has Just Spent US$56k Buying Shares
10:24am, Wednesday, 15'th Jan 2020
Whilst it may not be a huge deal, we thought it was good to see that the Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR...
Eiger BioPharmaceuticals Appoints Industry Veteran Eldon Mayer as Executive Vice President and Chief Commercial Officer
01:00pm, Tuesday, 07'th Jan 2020
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a late-stage clinical biopharmaceutical company focused on the development and commercialization of targeted therapies for serious rare and ultra-rare dis
Eiger Updates on 2019 Progress and 2020 Milestones Expected
01:00pm, Monday, 06'th Jan 2020
Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), a late-stage biopharmaceutical company focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, t
Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), a late stage clinical biopharmaceutical company focused on the development and commercialization of targeted therapies for serious rare and ultra-rare di
Hedge Funds Have Never Been This Bullish On Eiger BioPharmaceuticals, Inc. (EIGR)
06:33am, Saturday, 07'th Dec 2019
Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics have to say about hedge
